| abstract |
Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection: n n n The disclosed processes use S N Ar-type coupling reactions between peptidic compounds having a hydroxyproline moiety of the following formula: n nand halogenated or sulfonated bromoquinoline compounds. |